TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) have proven efficacy against human immunodeficiency virus type 1 (HIV-1). However, in the setting of incomplete viral suppression, efavirenz and nevirapine select for resistant viruses. The diarylpyrimidine etravirine has demonstrated durable e...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Azijn, Hilde, Tirry, Ilse, Vingerhoets, Johan, de Béthune, Marie-Pierre, Kraus, Guenter, Boven, Katia, Jochmans, Dirk, Van Craenenbroeck, Elke, Picchio, Gaston, Rimsky, Laurence T.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2010
Teme:
Antiviral Agents
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2812151/
https://ncbi.nlm.nih.gov/pubmed/19933797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00986-09
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki